Literature DB >> 10193321

Chlamydia pneumoniae in atheroma: consideration of criteria for causality.

A Shor1, J I Phillips, G Ong, B J Thomas, D Taylor-Robinson.   

Abstract

AIMS: (1) To seek evidence of the existence of Chlamydia pneumoniae in a spectrum of atheromatous lesions in different types of arteries from individuals of different ages, using a polymerase chain reaction (PCR) assay supported by electron microscopy and immunocytochemistry; (2) to use electron microscopy to examine interactions between C pneumoniae and the cells present in the arterial tissue; (3) to assess the extent to which the data fulfil the criteria for causality.
METHODS: At necropsy examination, 35 arterial specimens were taken from 25 subjects. The grade of atheroma was determined macroscopically and microscopically and the tissues coded and examined by the three techniques.
RESULTS: Of the 35 specimens, 24 had macroscopic or microscopic atheromatous lesions of varying degree. Twenty two of the 35 specimens were examined by electron microscopy, C pneumoniae-like bodies being found in 11 (50%); seven specimens were examined by the immunocytochemical method, positive staining being detected in three; and all specimens were examined by the PCR technique, 15 (43%) being PCR positive. Overall, of the 24 specimens with lesions, 17 (71%) were positive by at least one of the three tests, whereas of the 11 specimens without lesions, only one was positive. The positive specimens comprised 10 of 19 aortas, three of six iliac arteries, and one coronary and one pulmonary artery. C pneumoniae was detected in four of six specimens in which there were early changes and in a 20 year old subject. Concerning the 25 subjects, of 17 who had atheromatous arteries, 14 (82%) were C pneumoniae positive and of the eight who had normal arteries, none was positive.
CONCLUSIONS: There is a strong correlation between C pneumoniae and arterial atheromatous lesions. The organism may contribute to the disease process by damaging smooth muscle cells.

Entities:  

Mesh:

Year:  1998        PMID: 10193321      PMCID: PMC500974          DOI: 10.1136/jcp.51.11.812

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  38 in total

1.  THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION?

Authors:  A B HILL
Journal:  Proc R Soc Med       Date:  1965-05

2.  Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction.

Authors:  M Leinonen; E Linnanmäki; K Mattila; M S Nieminen; V Valtonen; M Leirisalo-Repo; P Saikku
Journal:  Microb Pathog       Date:  1990-07       Impact factor: 3.738

3.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

4.  Ochronosis in black South Africans who used skin lighteners.

Authors:  J I Phillips; C Isaacson; H Carman
Journal:  Am J Dermatopathol       Date:  1986-02       Impact factor: 1.533

5.  Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease.

Authors:  D H Thom; S P Wang; J T Grayston; D S Siscovick; D K Stewart; R A Kronmal; N S Weiss
Journal:  Arterioscler Thromb       Date:  1991 May-Jun

6.  Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease.

Authors:  D H Thom; J T Grayston; D S Siscovick; S P Wang; N S Weiss; J R Daling
Journal:  JAMA       Date:  1992-07-01       Impact factor: 56.272

7.  Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study.

Authors:  P Saikku; M Leinonen; L Tenkanen; E Linnanmäki; M R Ekman; V Manninen; M Mänttäri; M H Frick; J K Huttunen
Journal:  Ann Intern Med       Date:  1992-02-15       Impact factor: 25.391

8.  Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques.

Authors:  A Shor; C C Kuo; D L Patton
Journal:  S Afr Med J       Date:  1992-09

9.  A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.

Authors:  J T Grayston; C C Kuo; S P Wang; J Altman
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245

10.  Lack of cilia and squamous metaplasia in upper respiratory tract biopsies from children.

Authors:  J I Phillips
Journal:  S Afr Med J       Date:  1989-10-07
View more
  9 in total

Review 1.  Microorganisms in the aetiology of atherosclerosis.

Authors:  S A Morré; W Stooker; W K Lagrand; A J van den Brule; H W Niessen
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

Review 2.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 3.  Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence.

Authors:  Margareta M Ieven; Vicky Y Hoymans
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

4.  Chlamydia pneumoniae in infrequently examined blood vessels.

Authors:  D Taylor-Robinson; B J Thomas; R Goldin; R Stanbridge
Journal:  J Clin Pathol       Date:  2002-03       Impact factor: 3.411

5.  Effect of clarithromycin treatment on Chlamydia pneumoniae in vascular tissue of patients with coronary artery disease: a randomized, double-blind, placebo-controlled trial.

Authors:  Hans F Berg; Boulos Maraha; Anneke van der Zee; Siska K Gielis; Paul J M Roholl; Gert-Jan Scheffer; Marcel F Peeters; Jan A J W Kluytmans
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

6.  Host cell cytokines induced by Chlamydia pneumoniae decrease the expression of interstitial collagens and fibronectin in fibroblasts.

Authors:  Jürgen Baumert; Karl-Hermann Schmidt; Annett Eitner; Eberhard Straube; Jürgen Rödel
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

7.  Is the perceived association between Chlamydia pneumoniae and vascular diseases biased by methodology?

Authors:  Boulos Maraha; Hans Berg; Marjolein Kerver; Steef Kranendonk; Jaap Hamming; Jan Kluytmans; Marcel Peeters; Anneke van der Zee
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

8.  Reduced atherosclerotic lesion size in P-selectin deficient apolipoprotein E-knockout mice fed a chow but not a fat diet.

Authors:  Marie-Claude Bourdillon; Jacques Randon; Lydie Barek; Kazem Zibara; Chantal Covacho; Robin N Poston; Elza Chignier; John L McGregor
Journal:  J Biomed Biotechnol       Date:  2006

9.  Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review.

Authors:  Marek Smieja; James Mahony; Astrid Petrich; Jens Boman; Max Chernesky
Journal:  BMC Infect Dis       Date:  2002-10-01       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.